Cargando…

Activation of NRF2 Signaling Pathway Delays the Progression of Hyperuricemic Nephropathy by Reducing Oxidative Stress

Hyperuricemia (HUA)-induced oxidative stress is a crucial contributor to hyperuricemic nephropathy (HN), but the molecular mechanisms underlying the disturbed redox homeostasis in kidneys remain elusive. Using RNA sequencing, together with biochemical analyses, we found that nuclear factor erythroid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Panshuang, Sun, Yi, Wang, Yiming, Lin, Simei, An, Yongpan, Wang, Liang, Liu, Jihan, Huang, Yajun, Yang, Baoxue, Zhou, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215166/ https://www.ncbi.nlm.nih.gov/pubmed/37237889 http://dx.doi.org/10.3390/antiox12051022

Ejemplares similares

Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy
por: Shi, Yingfeng, et al.
Publicado: (2020)

Baicalein decreases uric acid and prevents hyperuricemic nephropathy in mice
por: Meng, Xiaolu, et al.
Publicado: (2017)

Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats
por: Liu, Na, et al.
Publicado: (2017)

Pharmacologic Targeting of BET Proteins Attenuates Hyperuricemic Nephropathy in Rats
por: Xiong, Chongxiang, et al.
Publicado: (2021)

Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy
por: Bao, Jinfang, et al.
Publicado: (2018)

Evaluation of renal microperfusion in hyperuricemic nephropathy by contrast-enhanced ultrasound imaging
por: He, Li, et al.
Publicado: (2022)

Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
por: Hu, Yan, et al.
Publicado: (2022)

Urea Transporter Inhibitor 25a Reduces Ascites in Cirrhotic Rats
por: Ying, Yi, et al.
Publicado: (2023)

Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy
por: He, Li, et al.
Publicado: (2017)

Oridonin Delays Aging Through the AKT Signaling Pathway
por: An, Yongpan, et al.
Publicado: (2022)

Treatment with a PPAR-γ Agonist Protects Against Hyperuricemic Nephropathy in a Rat Model
por: Wang, Xin, et al.
Publicado: (2020)

Anti-Hyperuricemic and Uricosuric Potential of Berberis vulgaris in Oxonate-Induced Hyperuricemic Rats
por: Bilal, Muhammad, et al.
Publicado: (2021)

A novel heterozygous missense mutation in the UMOD gene responsible for Familial Juvenile Hyperuricemic Nephropathy
por: Calado, Joaquim, et al.
Publicado: (2005)

Anti-Hyperuricemic and Nephroprotective Effects of Dihydroberberine in Potassium Oxonate- and Hypoxanthine-Induced Hyperuricemic Mice
por: Xu, Lieqiang, et al.
Publicado: (2021)

Endothelial injury and inflammation in patients with hyperuricemic nephropathy at chronic kidney disease stages 1-2 and 3-4
por: Xu, Li, et al.
Publicado: (2022)

Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways
por: Ren, Qian, et al.
Publicado: (2022)

Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
por: Qiao, Panshuang, et al.
Publicado: (2022)

Crucial role of serum response factor in renal tubular epithelial cell epithelial-mesenchymal transition in hyperuricemic nephropathy
por: Zhao, Long, et al.
Publicado: (2019)

Hyperuricemic PRP in Tendon Cells
por: Andia, I., et al.
Publicado: (2014)

A Novel UMOD Mutation (c.187T>C) in a Korean Family with Juvenile Hyperuricemic Nephropathy
por: Lee, Mi-Na, et al.
Publicado: (2013)

A novel heterozygous missense mutation in uromodulin gene in an Indian family with familial juvenile hyperuricemic nephropathy
por: Saxena, D., et al.
Publicado: (2016)

Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota
por: Zhao, Zhen Xiong, et al.
Publicado: (2022)

Possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—Fructose‐supplemented rats
por: El‐Kafoury, Bataa M. A., et al.
Publicado: (2019)

Randomized control trial for the assessment of the anti-albuminuric effects of topiroxostat in hyperuricemic patients with diabetic nephropathy (the ETUDE study)
por: Kato, Sawako, et al.
Publicado: (2016)

Mangiferin Ameliorates Hyperuricemic Nephropathy Which Is Associated With Downregulation of AQP2 and Increased Urinary Uric Acid Excretion
por: Li, Xuechen, et al.
Publicado: (2020)

Insoluble Fiber in Barley Leaf Attenuates Hyperuricemic Nephropathy by Modulating Gut Microbiota and Short-Chain Fatty Acids
por: Li, Yongmei, et al.
Publicado: (2022)

A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy
por: Beddhu, Srinivasan, et al.
Publicado: (2016)

A Japanese Family Suffering from Familial Juvenile Hyperuricemic Nephropathy due to a Rare Mutation of the Uromodulin Gene
por: Nakayama, Mayuka, et al.
Publicado: (2012)

Anti-Hyperuricemic Effect of 2-Hydroxy-4-methoxy-benzophenone-5-sulfonic Acid in Hyperuricemic Mice through XOD
por: Yong, Tianqiao, et al.
Publicado: (2018)

Simiao pill inhibits epithelial mesenchymal transition in a mouse model of chronic hyperuricemic nephropathy by inhibiting NLRP3 inflammasome activation
por: Shui, Guangxing, et al.
Publicado: (2022)

Effect of androgen on bone metabolism in hyperuricemic rats
por: Ling, Li, et al.
Publicado: (2020)

A Case of Familial Juvenile Hyperuricemic Nephropathy with Novel Uromodulin Gene Mutation, a Novel Heterozygous Missense Mutation in Korea
por: Lee, Dong Hun, et al.
Publicado: (2010)

Baicalin Alleviates Oxidative Stress and Inflammation in Diabetic Nephropathy via Nrf2 and MAPK Signaling Pathway
por: Ma, Leyi, et al.
Publicado: (2021)

Effects of resveratrol on the inflammatory response and renal injury in hyperuricemic rats
por: Xiao, Benxi, et al.
Publicado: (2021)

Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model Rats
por: Asakawa, Shinichiro, et al.
Publicado: (2017)

Effects of rosuvastatin on serum glucose and insulin in hyperuricemic rats
por: Xilifu, Dilidaer, et al.
Publicado: (2022)

Evaluation the effectiveness of the Jiangniaosuan formulation in the treatment of hyperuricemic nephropathy in patients with chronic kidney disease stages 3–4: Study protocol of a randomized controlled trial
por: Lu, Lili, et al.
Publicado: (2023)

Oxymatrine ameliorates myocardial injury by inhibiting oxidative stress and apoptosis via the Nrf2/HO-1 and JAK/STAT pathways in type 2 diabetic rats
por: Huang, Yongpan, et al.
Publicado: (2023)

Human umbilical cord mesenchymal stem cells reduce oxidative damage and apoptosis in diabetic nephropathy by activating Nrf2
por: Nie, Ping, et al.
Publicado: (2021)

First Report of Familial Juvenile Hyperuricemic Nephropathy (FJHN) in Iran Caused By a Novel De Novo Mutation (E197X) in UMOD
por: Malakoutian, Tahereh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5at5gam09b27eqpf3tjs85m069